ReviewMicroorganisms2026
Advances in Decoding Bacterial N-Terminal Proteoforms: Technologies, Challenges, and Functional Insights.
Review in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The bacterial proteome is a highly dynamic landscape rather than simply a static reflection of the genome. Recent research has revealed that proteome complexity extends far beyond canonical gene annotation, with N-terminal (Nt-)proteoforms emerging as an important underexplored additional regulatory layer. These molecular variants originate from a single genetic locus through alternative translation initiation at internal or external in-frame start sites, thereby generating N-terminal heterogeneity that can influence protein stability, subcellular localization, interaction networks, and the stoichiometric assembly of multiprotein complexes. While recent advances in riboproteogenomics, N-terminomics, and computational annotation strategies have enabled proteoform mapping at single-amino-acid resolution, rapid high-throughput discovery currently outpaces downstream functional characterization. This review discusses the technological advances driving Nt-proteoform discovery, including emerging ribosome profiling and proteogenomic approaches, and further evaluates strategies for the functional characterization of Nt-proteoforms. Particular emphasis is placed on the transition from conventional plasmid-based heterologous expression systems towards precise genome-engineering approaches that enable selective manipulation of alternative translation initiation events within their native genomic context. Such targeted strategies are essential to bridge the gap between Nt-proteoform identification and functional understanding, ultimately uncovering how individual bacterial genomic loci can encode proteoforms with distinct and potentially divergent functional roles in bacterial physiology and pathogenesis. Ultimately, we hypothesize that alternative translation initiation represents a biologically meaningful post-transcriptional regulatory mechanism that contributes to maximizing prokaryotic coding capacity without expanding genome size, rather than merely constituting stochastic translational noise.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.